Solanum sodomaeum L. is a solanaceous plant native to wide areas of the Libyan desert. In a previous paper, the antineoplastic activity of the mixture of glycoalkaloids extracted from the fruits of S. sodomaeum L. against Sarcoma 180 in mice was reported.
Solanum sodomaeum L. is a solanaceous plant native to wide areas of the Libyan desert. In a previous paper, the antineoplastic activity of the mixture of glycoalkaloids extracted from the fruits of S. sodomaeum L. against Sarcoma 180 in mice was reported.
1) The glycoalkaloids extracted from the fruits, leaves and stems of this plant were investigated using MS and HPLC analyses, and solamargine and solasonine were identified in all the plant materials.
2) Furthermore, it was reported that a cream formulation containing purified glycoalkaloids from the fruits of the title plant was effective in the treatment of malignant human skin tumours; basal cell carcinomas, squamous cell carcinomas and benign tumours; keratoses and keratoacanthomas.
3) Regarding another constituents of the fruits of S. sodomaeum L., two new pyrrole alkaloids were studied. 4) Here we describe the isolation and structural elucidation of a new steroidal glycoside from the underground parts of S. sodomaeum L., along with seven known steroidal glycosides, one of whose structures was corrected. Additionally, we report their antiproliferative activity against human promyelocytic leukemia (HL-60) cells.
The MeOH extract of the underground parts of S. sodomaeum L. was successively subjected to Diaion HP20, silica gel, Sephadex LH20 and Chromatorex ODS column chromatographies, as well as HPLC on ODS, to afford eight steroidal glycosides (1) (2) (3) (4) (5) (6) (7) (8) .
Compounds 3-8 were identified as solamargine (3), 7) dioscin (6), 8) indioside D (7) 7) and protodioscin (8), 9) respectively, based on their physical and spectral data.
Compound 1 was obtained as an amorphous powder, and its positive FAB-MS showed [MϩNa] ϩ ion peak at m/z 1053. The molecular formula of 1 was determined to be C 51 C-NMR spectrum of the aglycone (Ag) moiety of 1 gave signals similar to those of 6, apart from the appearance of the signals due to one methoxyl carbon (d 55.6) and one hemiacetal carbon (d 103.1) and the lack of the signal due to one oxygenated methylene carbon. These NMR signals were assigned in detail with the aid of 1 H-1 H correlation spectroscopy (COSY), heteronuclear multiple quantum coherence (HMQC), heteronuclear multiple bond correlation (HMBC), and nuclear Overhauser and exchange spectroscopy (NOESY) spectra. The HMBC correlations and the coupling constant value for H-26 of Ag (d, Jϭ8 Hz) indicated 1 to be a tetraglycoside of 26b-methoxy diosgenin as shown in Fig. 1 . On acidic hydrolysis, 1 afforded D-glucose, L-rhamnose and D-xylose. Furthermore, the 13 C-NMR data of the Ag moiety and the sugar moiety were quite similar to those of (25R,26R)-26-methoxyspirost-5-en-3b-ol 10) and xylosyl-b-solamarine, 11) respectively. Based on these data, 1 was defin- 13 C-NMR signals were assigned in detail by the techniques similar to those of 1. In the HMBC spectrum, key correlations of the Ag moiety were observed as illustrated in Fig. 1 . From these findings, 2 was established as a pregnane glycoside, possessing an alkaloid ester group and triglycosyl group. The 12) in the 1 H-NMR spectrum. However, the configurations at C-23 of Ag and C-25 of Ag have not been confirmed. Consequently, 2 was elucidated to be 3b,16b-dihydroxy-pregn 13) However, the 1 H-and 13 C-NMR data of 2 were quite similar to those of abutiloide O. Therefore, 2 was con- Fig. 2. Structures of 1-8 sidered to be identical with abutiloide O, which was finally confirmed by direct comparison with the 1 H-NMR spectrum of an authentic sample. Based on this evidence, the structure of abutiloside O is corrected as shown in Fig. 2 .
The in vitro antiproliferative activity of 1-8 against HL-60 cells was examined. Compounds 3, 5-8 showed stronger activity than cisplatin (Table 2) . Recently, the cytotoxic activity of 5, 6 and 8 against HL-60 cells using a modified 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide assay was reported by Mimaki et al., 14) and the present results were similar to theirs.
To the best of our knowledge, 1 is a new compound, and the isolation of 2 and 4-8 from S. sodomaeum L. is described here for the first time.
Experimental
All instruments and materials used were the same as those cited in a previous report, 15) unless otherwise specified. Plant Material The underground parts of Solanum sodomaeum L. were collected in the Medical Plant Garden of Kumamoto University, Kumamoto prefecture, Japan, in October 2002, and identified by Professor Toshihiro Nohara, Faculty of Pharmaceutical Sciences, Kumamoto University.
Extraction and Isolation The cut fresh underground parts of Solanum sodomaeum L. (1200 g) were extracted with MeOH (1300 ml) at room temperature, and the solvent was removed under reduced pressure to give a syrup (27.7 g). The MeOH extract was chromatographed over Diaion HP20 (H 2 O, MeOH, acetone) to give fractions (frs.) 1-3. Fraction 2 (10. C-NMR data: see Table 1 .
Acidic Hydrolysis of 1 Compound 1 (6 mg) in 2 N HCl-dioxane (1 : 1, 2 ml) was heated at 95°C for 1 h. The reaction mixture was neutralized with 2 N NaOH and then evaporated under reduced pressure to give a residue. Cell Culture and Assay of Antiproliferative Activity HL-60 cells were obtained from the Japanese Cancer Research Resources Bank (HCRB), Tokyo. The cells were routinely cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum, 0.1 mg/ml streptomycin, and 100 U/ml penicillin at 37°C in a humidified atmosphere containing 5% CO 2 . The samples were dissolved in DMSO, sterilized by filtration through filter paper (0.45 mm), and 100 ml of each was added to 2 ml of culture media containing 10 5 cells. As a control, 100 ml of DMSO was used instead of sample. At 72 h after the start of incubation under 5% CO 2 at 37°C, viable cells were counted by the trypan blue exclusion method. The GI 50 value (mM) was defined as the concentration of sample necessary to inhibit the growth to 50% of the control. Cisplatin (Nippon Kayaku Co., Tokyo) was used as a standard sample.
